HOME >> MEDICINE >> NEWS
Asthma home intervention cost-effective for inner-city children, research reveals

CHAPEL HILL Through efforts to limit exposure to environmental irritants, health workers and municipalities can cut illness generally among inner-city children with asthma and also the number of clinic visits for those young patients by at least 19 percent, a new study concludes. The cost can be as low as $1,469 per affected family.

Last year, researchers reported in the New England Journal of Medicine that an intervention designed to reduce exposures of children with asthma to irritants and allergens at home succeeded in partially curtailing disruptive and sometimes life-threatening symptoms.

The latest part of the multi-center study evaluated the cost-effectiveness of those home-based efforts, which included buying impermeable mattress and pillow covers for each child. It showed that the statistically significant reductions in sickness and associated health-care use substantially offset the intervention's cost.

Expenses arose from administering an allergy skin test, hiring and training high school graduates as environmental counselors, buying air filters and vacuum cleaners and engaging pest management services when needed. Vacuum cleaners served to effectively remove cockroach droppings, dust mites, animal dander and other dirt that can trigger asthma attacks in susceptible people.

The cost per symptom-free day for each child was $25.57, investigators found. Asthmatic children in the study used 13 percent fewer B-agonist inhalers for relieving symptoms over the two-year study.

Dr. Meyer Kattan of Mount Sinai School of Medicine, Dr. Sally Stearns of the University of North Carolina at Chapel Hill School of Public Health and colleagues conducted the study. A report on their work appears in the current issue of the Journal of Allergy and Clinical Immunology.

"We demonstrated that a comprehensive home-based environmental intervention that was tailored to the child's exposures resulted in decreased symptoms and unschedu
'"/>

Contact: David Williamson
rdtokids@email.unc.edu
919-962-8596
University of North Carolina at Chapel Hill
25-Oct-2005


Page: 1 2

Related medicine news :

1. NHLBI Asthma Clinical Research Networks and ALA ACRC Network to present at ATS 2007
2. Asthmatx completes enrollment in pivotal study of bronchial thermoplasty
3. Asthma study shows patients have more options to control disease
4. Asthma linked to soot from diesel trucks in Bronx
5. Asthma risk increased in women with high levels of fat tissue inflammatory protein
6. Asthmatic children in multi-family housing hit by indoor nitrogen dioxide
7. Asthma inhalers adopted more slowly for minority patients and children
8. Asthma patients report better asthma control when seeing an allergist
9. Asthma research sounds warning for older Australians
10. Asthma drug fluticasone works as well as other drugs at half the dose
11. Asthmatics naturally deficient in antiviral immunity, report scientists

Post Your Comments:
(Date:3/6/2015)... Protein identification is increasingly being ... science research including drug discovery, diagnostics, immunology and ... was valued at $1,569.00 million in 2014 and ... 10.63% to reach $2,600.28 million in 2019. , ... protein based on protein size, shape, sequence and ...
(Date:3/6/2015)... As healthcare providers create one ... from disparate systems, they are using OnBase by ... efficiency. Enterprise content management (ECM) solutions ... IT solutions, including electronic medical records (EMR), enterprise ... , The following organizations have recently integrated ...
(Date:3/6/2015)... March 06, 2015 Saving Moses, a ... the world is traveling to Angola, Africa March 7-14 ... their malnutrition program. , This will be the organizations ... Angola, demonstrating their commitment to the region’s population by ... team will engage with the mothers and babies of ...
(Date:3/6/2015)... 06, 2015 Follow us on ... pharmacokinetics of a drug refers to testing of absorption, ... an organism. When toxicity studies are clubbed together with ... ADME/Tox. Increasing focus on lowering costs and time during ... worldwide. The traditional drug development model uses toxicity and ...
(Date:3/6/2015)... March 06, 2015 “On Tap” takes the ... the grand stage, to the silver screen and to modern ... precision toe-tapping numbers and their famous eye-high kicks! Producers, directors ... rich history of tap dancing in this robust show, showcasing ... of the United States. , “On Tap” is proud ...
Breaking Medicine News(10 mins):Health News:Protein Identification Market worth $2,600.28 Million By 2019 - New Research Report by MarketsandMarkets 2Health News:Protein Identification Market worth $2,600.28 Million By 2019 - New Research Report by MarketsandMarkets 3Health News:Healthcare Providers Select OnBase by Hyland to Improve Patient Care and Streamline Administrative Departments 2Health News:Healthcare Providers Select OnBase by Hyland to Improve Patient Care and Streamline Administrative Departments 3Health News:Saving Moses Returns to Angola to Continue Giving Infants and Children a Chance to Live 2Health News:Growing Need to Reduce Drug Development Costs Drives the Global ADME-Toxicology Testing Market, According to a New Report by Global Industry Analysts, Inc. 2Health News:Growing Need to Reduce Drug Development Costs Drives the Global ADME-Toxicology Testing Market, According to a New Report by Global Industry Analysts, Inc. 3Health News:The Legacy Dancers, a Dazzling Dance Troupe of Former Rockettes, Kick to New Heights in “On Tap: From Broadway to the Silver Screen” 2
(Date:3/6/2015)... , March 6, 2015  Palatin Technologies, Inc. (NYSE MKT: ... 27 th Annual ROTH Conference on Wednesday, March 11, ... held at the Ritz Carlton Laguna Niguel in ... Spana , Ph.D., President and Chief Executive Officer of Palatin ... programs. About Palatin Technologies, Inc. ...
(Date:3/6/2015)... , March 6, 2015   Hospira, Inc. ... Food and Drug Administration (FDA) on today,s FDA approval of ... . This is a watershed moment for improving patient access ... leading global provider of biosimilars, Hospira has seen first-hand the ... a proud participant in these early stages of the development ...
(Date:3/6/2015)... March 6, 2015  Aethlon Medical, Inc. (OTCQB:AEMD), the ... diseases and cancer, today announced that James A. ... present a corporate overview at the 27th Annual ROTH ... time.  Aethlon was previously scheduled to present at 5:30 ... will be held at The Ritz-Carlton Hotel in ...
Breaking Medicine Technology:Hospira Statement on FDA Approval of the First Biosimilar in the United States 2Hospira Statement on FDA Approval of the First Biosimilar in the United States 3Update - Changed Time for Aethlon Medical Presentation at the 27th Annual ROTH Conference 2
Cached News: